US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 32.270
  • -0.470-1.44%
Close Apr 7 16:00 ET
  • 32.270
  • 0.0000.00%
Post 17:04 ET
1.80BMarket Cap24.45P/E (TTM)

Supernus Pharmaceuticals Key Stats

Supernus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 154.219M--
--2025/Q1-- / 146.736M--
Feb 25, 20252024/Q4174.159M / 155.252M--
Nov 4, 20242024/Q3175.689M / 157.298M--
Aug 6, 20242024/Q2168.325M / 148.852M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 154.219M--
--2025/Q1-- / 146.736M--
Feb 25, 20252024/Q4174.159M / 155.252M--
Nov 4, 20242024/Q3175.689M / 157.298M--
Aug 6, 20242024/Q2168.325M / 148.852M--

Unlock Free Earnings Estimates

Supernus Pharmaceuticals Earnings Reports

Read more

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More